Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 401–500 of 1,033
Alexander, B. D., Ashley, E. D., Reller, L. B., & Reed, S. D. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.10.011 · Cited by 125
“(Wisplinghoff et al., 2004).”
BackgroundInfluentialKelly‐Quintos, C., Cavacini, L. A., Posner, M. R., Goldmann, D. A., & Pier, G. B. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2742-2750.2006 · Cited by 121
“epidermidis strains that express this antigen (18), and these strains constitute a significant proportion of clinical isolates (36).”
BackgroundSynthesis and biological evaluation of amphotericin B derivatives
Volmer, A. A., Szpilman, A. M., & Carreira, E. M. (2010) · Natural Product Reports · doi:10.1039/b820743g · Cited by 119
Nguyen, H. M., & Graber, C. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp377 · Cited by 132
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Tumbarello, M., Repetto, E. C., Trecarichi, E. M., Bernardini, C., PASCALE, G. D., Parisini, A., Rossi, M., Molinari, M. P., Spanu, T., Viscoli, C., et al. (2011) · Epidemiology and Infection · doi:10.1017/s0950268810003055 · Cited by 155
“most frequently isolated pathogen from blood culture among Gram-negative rods and the seventh among all pathogens [4, 5].”
Su, L., Han, B., Liu, C., Liang, L., Jiang, Z., Deng, J., Yan, P., Jia, Y., Feng, D., & Xie, L. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-157 · Cited by 134
“In the United States, approximately 500,000 people die of sepsis each year [1,2].”
BackgroundPfaller, M. A., Cormican, M., Flamm, R. K., Mendes, R. E., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy344 · Cited by 126
Dagnew, M., Yismaw, G., Gizachew, M., Gadisa, A., Abebe, T., Tadesse, T., Alemu, A., & Mathewos, B. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-283 · Cited by 125
“More or less similar observations have been made in cases of bacteraemia in different countries, however, the proportion and predominance of the organisms varied [5,12,18,19,22,24].”
BackgroundJubrail, J., Morris, P., Bewley, M. A., Stoneham, S., Johnston, S. A., Foster, S. J., Peden, A. A., Read, R. C., Marriott, H. M., & Dockrell, D. H. (2016) · Cellular Microbiology · doi:10.1111/cmi.12485 · Cited by 120
“Staphylococcus aureus is a major cause of infectious disease contributing both to community-associated and hospital-associated infection (Fluit et al., 2000; Wisplinghoff et al., 2004).”
BackgroundClinical outcomes of type III Pseudomonas aeruginosa bacteremia*
El-Solh, A. A., Hattemer, A., Hauser, A. R., Alhajhusain, A., & Vora, H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182377906 · Cited by 120
“(1) (n 5 37) Type III Secretion System”
BackgroundInfluentialLau, A., Halliday, C., Chen, S. C.-A., Playford, E. G., Stanley, K., & Sorrell, T. C. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01650-09 · Cited by 118
“Candida spp. rank as the third most common cause of nosocomial BSIs in the United States (39) and the eighth most common cause of all BSIs in Australia and Europe (3, 5).”
BackgroundMenz, B. D., Charani, E., Gordon, D. L., Leather, A. J., Moonesinghe, S. R., & Phillips, C. J. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s319780 · Cited by 118
“faecium isolates displaying resistance to vancomycin.(47) While there are many phenotypes of resistance within the Enterococcus spp.”
BackgroundAcquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase
Kahn, J. N., Garcia-Effron, G., Hsu, M.-J., Park, S., Marr, K. A., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00067-07 · Cited by 118
“, remains high (7, 16, 18) and treatment options are limited due to intrinsic resistance to fluconazole (1).”
BackgroundThe Relation between Oral Candida Load and Bacterial Microbiome Profiles in Dutch Older Adults
Kraneveld, E. A., Buijs, M. J., Bonder, M. J., Visser, M., Keijser, B. J. F., Crielaard, W., & Zaura, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042770 · Cited by 118
“the fourth leading cause of all cases [9].”
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines
Bromuro, C., Romano, M. R., Chiani, P., Berti, F., Tontini, M., Proietti, D., Mori, E., Torosantucci, A., Costantino, P., Rappuoli, R., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.012 · Cited by 130
“Deep-seated fungal infections are increasingly common in hositalized patients and carry a high mortality toll even in the resence of antifungal therapy, which is limited by toxicity, emerence of resistance and high cost [1–7].”
BackgroundBloodstream Infections: The peak of the iceberg
Viscoli, C. (2016) · Virulence · doi:10.1080/21505594.2016.1152440 · Cited by 154
“In terms of health-care-associated infections a pivotal study by Hilmar Wisplinghoff and coworkers in 2003 (4), reported more than 24000 cases of BSI in 49 US hospitals over a 7-year period, with an incidence of 6 cases/100.”
BackgroundStamper, P. D., Cai, M., Howard, T., Speser, S., & Carroll, K. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00552-07 · Cited by 118
“Antimicrobial resistance to methicillin is on the rise (11, 40), complicating patient management (32, 39).”
BackgroundExploring the oral-gut linkage: Interrelationship between oral and systemic diseases
Yamazaki, K., & Kamada, N. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.11.006 · Cited by 134
“Among them, Klebsiella pneumoniae and Klebsiella aeromobilis are well-known as agents of hospital-acquired infection 29 – 33 .”
Grimont, F., & Grimont, P. A. D. (2006) · Springer eBooks · doi:10.1007/0-387-30746-x_9 · Cited by 152
Fernández Guerrero, M. L., González López, J. J., Goyenechea, A., Fraile, J., & de Górgolas, M. (2009) · Medicine · doi:10.1097/md.0b013e318194da65 · Cited by 121
“aureus is the second most common microorganism producing hospital-acquired bacteremia in hospitals in the United States.(205) It has been estimated that 1% of hospital stays involve a staphylococcal infection.”
BackgroundInfluentialLebreton, F., Riboulet-Bisson, E., Serror, P., Sanguinetti, M., Posteraro, B., Torelli, R., Hartke, A., Auffray, Y., & Giard, J.-C. (2009) · Infection and Immunity · doi:10.1128/iai.01218-08 · Cited by 117
“Phone: (33) 231 565 410. Fax: ( 33 ) 231 565 311.”
Fibrinogen-binding proteins of Gram-positive bacteria
Ganesh, V. K., Höök, M., Speziale, P., & Rivera, J. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-03-0233 · Cited by 134
Zumbuehl, A., Ferreira, L., Kuhn, D. M., Astashkina, A. I., Long, L. A., Yeo, Y., Iaconis, T., Ghannoum, M. A., Fink, G. R., Langer, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705250104 · Cited by 127
Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy
Suppli, M. H., Aabenhus, R. M., Harboe, Z. B., Andersen, L. P., Tvede, M., & Jensen, J. S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03394.x · Cited by 119
“In the past decade Enterococcus spp. has become the third most common aetiological agent isolated in nosocomial bloodstream infections in the United States [2,3].”
BackgroundFungal Biofilms: Relevance in the Setting of Human Disease
Martinez, L. R., & Fries, B. C. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0035-5 · Cited by 115
“C. albicans is the third leading cause of infections related to intravascular catheters, with the second highest rate of colonization to infection and the overall highest crude mortality [23, 24 ].”
BackgroundIdentifying infection-associated genes of Candida albicans in the postgenomic era
Wilson, D., Thewes, S., Zakikhany, K., Fradin, C., Albrecht, A., Almeida, R., Brunke, S., Grosse, K., Martin, R., Mayer, F., et al. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00524.x · Cited by 115
Genetic susceptibility to Candida infections
Smeekens, S. P., van de Veerdonk, F. L., Kullberg, B. J., & Netea, M. G. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201678 · Cited by 115
“The mean time of onset of systemic Candida infections is 22 days after hospitalization (Wisplinghoff et al, 2004).”
Teoh, F., & Pavelka, N. (2016) · Pathogens · doi:10.3390/pathogens5010006 · Cited by 110
“One such cause is opportunistic microbial infections [6].”
BackgroundMiller, D. L., & O’Grady, N. P. (2012) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2012.04.023 · Cited by 118
Zheng, X.-F., Hong, Y.-X., Feng, G.-J., Zhang, G.-F., Rogers, H., Lewis, M. A. O., Williams, D. W., Xia, Z.-F., Song, B., & Wei, X.-Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063967 · Cited by 115
Guiton, P. S., Hannan, T. J., Ford, B. A., Caparon, M. G., & Hultgren, S. J. (2012) · Infection and Immunity · doi:10.1128/iai.00856-12 · Cited by 118
Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
Jia, C., Zhang, J., Yu, L., Wang, C., Yang, Y., Rong, X., Xu, K., & Chu, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00445 · Cited by 126
Fernández Guerrero, M. L., Goyenechea, A., Verdejo, C., Roblas, R. F., & de Górgolas, M. (2007) · Medicine · doi:10.1097/md.0b013e31815d5386 · Cited by 113
Chamilos, G., Lionakis, M. S., Lewis, R. E., Lopez‐Ribot, J. L., Saville, S. P., Albert, N. D., Halder, G., & Kontoyiannis, D. P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500950 · Cited by 115
Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus Infections
Drew, R. H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.227 · Cited by 116
Jang, H., Kim, S., Kim, K. H., Kim, C. J., Lee, S., Song, K., Jeon, J. H., Park, W. B., Kim, H. B., Park, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/600295 · Cited by 113
“teremia in the United States [2].”
King, J., Kulhánková, K., Stach, C. S., Vu, B. G., & Salgado‐Pabón, W. (2016) · mSphere · doi:10.1128/msphere.00071-16 · Cited by 125
“aureus is the leading cause of infective endocarditis, accounting for about 40,000 cases per year (34–37), and is the second leading cause of sepsis (34, 38, 39).”
BackgroundThangamani, S., Eldesouky, H. E., Mohammad, H., Pascuzzi, P. E., Avramova, L., Hazbun, T. R., & Seleem, M. N. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.029 · Cited by 113
“Candida albicans is the fourth leading cause of bloodstream infections in the United States and has been associated with a high mortality rate (50%) [51,52].”
BackgroundBritt, N. S., Potter, E. M., Patel, N., & Steed, M. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw815 · Cited by 120
“5 INTRODUCTION Infections due to vancomycin-resistant enterococci (VRE) are commonly encountered in the hospital and healthcare settings [1-4].”
BackgroundGarnacho-Montero, J., Diaz-Martin, A., Garcia-Cabrera, E., Ruiz Perez de Pipaon, M., Hernandez-Caballero, C., & Lepe-Jimenez, J. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 112
Shah, C. P., McKey, J., Spirn, M. J., & Maguire, J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.133405 · Cited by 117
“10%) in the intensive care unit.(1) The incidence of nosocomial”
BackgroundJohnson, J. K., Arduino, S., Stine, O. C., Johnson, J. A., & Harris, A. D. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00560-07 · Cited by 134
“Pseudomonas aeruginosa is a common pathogen that causes nosocomial infections in intensive care units (ICUs) (1, 28).”
BackgroundFungal vaccines: real progress from real challenges
Cassone, A. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70016-1 · Cited by 129
Rehm, S. J., Boucher, H. W., Levine, D. P., Campion, M., Eisenstein, B. I., Vigliani, G. A., Corey, G. R., & Abrutyn, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn372 · Cited by 119
“Staphylococcus aureus is the most common cause of infective endocarditis in many regions of the world(1) and in the USA is second only to coagulase-negative staphylococci in causing bacteraemia.(2) Since it was first described in 1961, methicillinresistant S.”
BackgroundTreatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
“In an often cited nationwide survey, Candida species were found to be the fourth most frequent causes of bloodstream infection in hospitalized patients in the US, and were associated with the highest mortality rate among leading bloodstream isolates [2].”
BackgroundCandida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy
Arnold, C. J., Johnson, M., Bayer, A. S., Bradley, S., Giannitsioti, E., Miró, J. M., Tornos, P., Tattevin, P., Strahilevitz, J., Spelman, D., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04867-14 · Cited by 110
“which is consistent with data indicating Candida as an emerging pathogen for nosocomial bloodstream infections (21).”
ResultInfluentialJones, C. J., & Wozniak, D. J. (2017) · mBio · doi:10.1128/mbio.00864-17 · Cited by 109
“These infections can present as acute and chronic infections of burn wounds, skin, and indwelling medical devices and can disseminate, resulting in sepsis (1, 2).”
BackgroundMartinez, R. M., & Wolk, D. M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0031-2016 · Cited by 124
Walz, J. M., Avelar, R. L., Longtine, K. J., Carter, K. L., Mermel, L. A., & Heard, S. O. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f265ba · Cited by 114
β-Lactamases identified in clinical isolates ofPseudomonas aeruginosa
Zhao, W., & Hu, Z. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.481763 · Cited by 117
“A survey of 49 US hospitals during 1995∼2002 showed that 4.3% of 20,978 monomicrobial bloodstream infections in hospitalized patients were caused by P. aeruginosa, with a crude mortality rate of 38.7% (Wisplinghoff et al. 2004).”
BackgroundInfluentialCisneros, J. M., Cobo-Reinoso, J., Pujol, M., Rodríguez‐Baño, J., & Salavert, M. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(07)74242-8 · Cited by 169
Zepelin, M. B.-V., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 111
“Species of the genus Candida are most frequently isolated as the cause of invasive fungal infections and they now rank as the fourth most common cause of nosocomial bloodstream infections in the USA, accounting for 8% to 15% of all hospital-acquired sepsis cases.(1,2) Longitudinal surveillance programmes in the USA an…”
BackgroundBiofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates
Vijayakumar, S., Rajenderan, S., Laishram, S., Anandan, S., Veeraraghavan, B., & Biswas, I. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00105 · Cited by 125
Innate Immune System Response to Burn Damage—Focus on Cytokine Alteration
Sierawska, O., Małkowska, P., Taşkın, C., Hrynkiewicz, R., Mertowska, P., Grywalska, E., Korzeniowski, T., Torres, K., Surowiecka, A., Niedźwiedzka‐Rystwej, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020716 · Cited by 129
“Invasive infection with molds such as Aspergillus is more closely associated with mortality [5,88].”
BackgroundEchinocandins for Candidemia in Adults without Neutropenia
Bennett, J. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmct060052 · Cited by 109
Dahl, A., Rasmussen, R. V., Bundgaard, H., Hassager, C., Bruun, L. E., Lauridsen, T. K., Moser, C., Sogaard, P., Arpi, M., & Bruun, N. E. (2013) · Circulation · doi:10.1161/circulationaha.112.001170 · Cited by 108
Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
Duerkop, B. A., Huo, W., Bhardwaj, P., Palmer, K. L., & Hooper, L. V. (2016) · mBio · doi:10.1128/mbio.01304-16 · Cited by 112
“faecalis is an opportunistic pathogen that causes intestinal dysbiosis and bloodstream infections (2, 3).”
Sligl, W., Taylor, G. D., & Brindley, P. G. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.07.003 · Cited by 112
“1 per 1000 admissions, however this included all hospitalized patients, not ICU patients alone.(11) The median time from admission to the development of bacteremia in our study was 18.”
BackgroundA Glucose Sensor in Candida albicans
Brown, V., Sexton, J. A., & Johnston, M. (2006) · Eukaryotic Cell · doi:10.1128/ec.00186-06 · Cited by 110
“In addition to causing ordinary vaginal and oral (thrush) infections, this fungus is a serious threat to immunocompromised patients, for whom disseminated, invasive candidiasis is common and often fatal (31, 56).”
BackgroundIn Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
Wong, S. S. W., Kao, R. Y. T., Yuen, K. Y., Wang, Y., Yang, D., Samaranayake, L. P., & Seneviratne, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085836 · Cited by 107
Anderson, A. S., Miller, A. A., Donald, R. G. K., Scully, I. L., Nanra, J. S., Cooper, D., & Jansen, K. U. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21872 · Cited by 116
“These results (1) further confirm the important role of ClfA in virulence and (2) underscore the important distinction between binding affinity and functional activity.”
ResultInfection control: the case for horizontal rather than vertical interventional programs
Wenzel, R. P., & Edmond, M. B. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.002 · Cited by 112
Self-citationOberoi, J. K., Wattal, C., Goel, N., Raveendran, R., Datta, S., & Prasad, K. (2012) · PubMed Central · Cited by 154
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
van Hal, S. J., Tong, S. Y. C., & Davis, J. S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1396906 · Cited by 118
Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
de Prost, N., Oro, S., Duong, T. A., Valeyrie‐Allanore, L., Legrand, P., Wolkenstein, P., Brochard, L. J., Brun‐Buisson, C., & Roujeau, J. (2010) · Medicine · doi:10.1097/md.0b013e3181ca4290 · Cited by 106
“BSI was defined as 1 blood culture yielding a recognized pathogen from a single sample or an organism of the normal skin flora (mainly coagulase-negative staphylococci) isolated from more than 1 culture within a 48-hour period.(34) Polymicrobial bacteremiawas defined as the recovery of 2 or more organisms from the sam…”
BackgroundChen, C., Tsay, W., Tang, J., Tien, H., Chen, Y., Chang, S., & Hsueh, P. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809991208 · Cited by 119
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
Galocha, M., Pais, P., Cavalheiro, M., Pereira, D., Viana, R., & Teixeira, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092345 · Cited by 105
“Of the various Candida species, Candida albicans and Candida glabrata not only account for 60% of Candida species present in the human body, but also constitute the most prevalent of the pathogenic Candida species, being responsible for more than 400,000 life-threatening infections worldwide every year [3,6].”
BackgroundLeón, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 118
“Candida species are responsible for between 9 and 12 % of all bloodstream infections [8] and are the fourth most common cause of nosocomial bloodstream infections in most US population surveys [8] and the sixth or seventh most common cause in European surveys [9].”
BackgroundBloodstream infections in the Intensive Care Unit
Bassetti, M., Righi, E., & Carnelutti, A. (2016) · Virulence · doi:10.1080/21505594.2015.1134072 · Cited by 127
Hentrich, M., Schalk, E., Schmidt‐Hieber, M., Chaberny, I. F., Mousset, S., Buchheidt, D., Ruhnke, M., Penack, O., Salwender, H. J., Wolf, H.-H., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt545 · Cited by 128
“aeruginosa] increased in patients with BSI in the US between 1995 and 2002 [38].”
BackgroundCandida albicans specializations for iron homeostasis: from commensalism to virulence
Noble, S. M. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.09.006 · Cited by 104
“Modern medical practices have nevertheless contributed to an increased incidence of candidemia, worldwide [11–13].”
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study
Bassetti, M., Merelli, M., Ansaldi, F., de Florentiis, D., Sartor, A., Scarparo, C., Callegari, A., & Righi, E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127534 · Cited by 105
“is currently the main protagonist of fungal infections in hospitalized patients, representing the fourth and sixth leading cause of nosocomial sepsis in European and US studies, respectively [1,2].”
BackgroundSupramolecular high-aspect ratio assemblies with strong antifungal activity
Fukushima, K., Liu, S., Wu, H., Engler, A. C., Coady, D. J., Maune, H., Pitera, J. W., Nelson, A., Wiradharma, N., Venkataraman, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms3861 · Cited by 105
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia
Sobel, J. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0016-6 · Cited by 128
“During this time period, the incidence of Candida BSIs steadily rose due to higher numbers of susceptible patients and invasive procedures [5, 6 ].”
BackgroundChi, H.-W., Yang, Y.-S., Shang, S.-T., Chen, K.-H., Yeh, K.-M., Chang, F.-Y., & Lin, J.-C. (2011) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2010.08.010 · Cited by 103
Wheeler, D. S., Giaccone, M. J., Hutchinson, N., Haygood, M., Bondurant, P., Demmel, K., Kotagal, U. R., Connelly, B. L., Corcoran, M. S., Line, K., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2601 · Cited by 112
Nicol, M., Alexandre, S., Luizet, J.-B., Skogman, M., Jouenne, T., Salcedo, S., & Dé, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010214 · Cited by 100
“This persistence is mostly linked to its capacity to form biofilms [5,6].”
BackgroundTreatment of multidrug resistant Acinetobacter
Murray, C. K., & Hospenthal, D. R. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000185985.64759.41 · Cited by 103
Glycopeptides: Update on an old successful antibiotic class
Pace, J., & Yang, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.005 · Cited by 122
Infectious complications in dialysis—epidemiology and outcomes
Li, P. K., & Chow, K. M. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.194 · Cited by 106
Heilmann, C. J., Sorgo, A. G., Siliakus, A. R., Dekker, H. L., Brul, S., de Koster, C. G., de Koning, L. J., & Klis, F. M. (2011) · Microbiology · doi:10.1099/mic.0.049395-0 · Cited by 105
“The opportunistic fungal pathogen Candida albicans is a leading cause of fungal death in a clinical setting (Wisplinghoff et al., 2004).”
BackgroundNishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Held, J., Kohlberger, I., Rappold, E., Busse Grawitz, A., & Häcker, G. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02473-12 · Cited by 102
“Candida species account for approximately 10% of bloodstream infections (BSI) in intensive care units (ICUs) and are associated with a crude in-hospital mortality rate of 30% (1, 2).”
BackgroundRole of TLR1 and TLR6 in the host defense against disseminated candidiasis
Netea, M. G., Van De Veerdonk, F., Verschueren, I., Van Der Meer, J. W. M., & Kullberg, B. J. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00353.x · Cited by 103
Zeise, K. D., Woods, R. J., & Huffnagle, G. B. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00323-20 · Cited by 97
“In addition to BSIs (termed “candidemia”), infections can be localized—as in OPC and VVC—or invasive, with invasive candidiasis (IC) accounting for the majority of deaths (73, 74).”
BackgroundBacterial infections in end-stage liver disease: current challenges and future directions
Bajaj, J. S., O’Leary, J. G., Wong, F. S.-H., Reddy, K. R., & Kamath, P. S. (2012) · Gut · doi:10.1136/gutjnl-2012-302339 · Cited by 109
Activity of Novel Synthetic Peptides against Candida albicans
Lum, K. Y., Tay, S. T., Le, C. F., Lee, V. S., Sabri, N. H., Velayuthan, R. D., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09657 · Cited by 110
Current Epidemiology of Candida Infection
Lockhart, S. R. (2014) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2014.08.001 · Cited by 101
Martínez‐Gomariz, M., Perumal, P., Mekala, S., Nombela, C., Chaffin, W. L., & Gil, C. (2009) · PROTEOMICS · doi:10.1002/pmic.200700594 · Cited by 101
“The inoculation of the blood stream from catheter biofilms is a major contributor to the position of Candida species as the third most common cause of nosocomial blood stream infection [5–7].”
BackgroundPortable microfluidic chip for detection of Escherichia coli in produce and blood
Demirci, U., Wang, S., Inci, Chaunzwa, Ramanujam, Vasudevan, Subramanian, Ip, A. C. F., Sridharan, & Gurkan (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29629 · Cited by 103
“On the other hand, sepsis is the tenth leading cause of death in the US,(5) amounting to 24,179 cases in 49 US hospitals over a period of 7 years.(6) As reported, E.”
Mellinghoff, S. C., Hoenigl, M., Koehler, P., Kumar, A., Lagrou, K., Lass‐Flörl, C., Meis, J. F., Menon, V., Rautemaa‐Richardson, R., & Cornely, O. A. (2018) · Mycoses · doi:10.1111/myc.12746 · Cited by 99
FEBRILE NEUTROPENIA IN ACUTE LEUKEMIA. EPIDEMIOLOGY, ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT
Hansen, B., Wendelbo, Ø., Bruserud, Ø., Hemsing, A. L., Mosevoll, K. A., & Reikvam, H. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.009 · Cited by 130
Treatment of invasive candidiasis in the elderly: a review
Dimοpoulos, G., Flevari, A., Θεοδωρακοπούλου, Μ., VELEGRAKI, & Armaganidis (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s39120 · Cited by 137
“%) and have become the fourth most common cause of hospital-acquired bloodstream infections (BSIs) in the USA.”
Antibacterial microemulsion prevents sepsis and triggers healing of wound in wistar rats
Ghosh, V., Saranya, S. R., Mukherjee, A., & Chandrasekaran, N. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.01.009 · Cited by 107
Kett, D. H., Shorr, A. F., Reboli, A. C., Reisman, A. L., Biswas, P., & Schlamm, H. T. (2011) · Critical Care · doi:10.1186/cc10514 · Cited by 100
“are now the third most frequent cause of nosocomial bloodstream infections in the intensive care unit (ICU), accounting for up to 10% to 15% of all septicemia cases in this setting [1,4-6].”
BackgroundTande, A. J., Palraj, R., Osmon, D. R., Berbari, E. F., Baddour, L. M., Lohse, C. M., Steckelberg, J. M., Wilson, W. R., & Sohail, M. R. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.09.006 · Cited by 112
Rodríguez‐Créixems, M., Alcalá, L., Muñóz, P., Cercenado, E., Vicente, T., & Bouza, E. (2008) · Medicine · doi:10.1097/md.0b013e318182119b · Cited by 126
Mai, A., Rotili, D., Massa, S., Brosch, G., Simonetti, G., Passariello, C., & Palamara, A. T. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.028 · Cited by 109
Mayer, F. L., Wilson, D., Jacobsen, I. D., Miramón, P., Slesiona, S., Bohovych, I. M., Brown, A. J. P., & Hube, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038584 · Cited by 99
“albicans also causes systemic infections with a crude mortality of approximately 37% [40].”
BackgroundAdrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock
Temmesfeld‐Wollbrück, B., Brell, B., Dávid, I., Dorenberg, M., Adolphs, J., Schmeck, B., Suttorp, N., & Hippenstiel, S. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0561-y · Cited by 103
“gene are frequently found in staphylococcal septicemia [29, 30, 31, 32].”
Background
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.